Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bob Y Liu

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Biology : CB|April 13, 2010
Primary cilia regulate branching morphogenesis during mammary gland developmentKimberly M McDermott, Bob Y Liu, Thea D Tlsty, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2004
The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cellsBob Y Liu, Sean P McDermott, Shariq S Khwaja, et al.
Oncogene|December 19, 2003
Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulationBob Y Liu, Young Chul Kim, Vicki Leatherberry, et al.
BMC Developmental Biology|February 20, 2007
Wnt signaling induces differentiation of progenitor cells in organotypic keratinocyte culturesMarni A Slavik, B Lynn Allen-Hoffmann, Bob Y Liu, et al.
Cancer Research|February 7, 2012
Mammary tumor regression elicited by Wnt signaling inhibitor requires IGFBP5Bob Y Liu, Irina Soloviev, XiaoDong Huang, et al.
Plos One|January 21, 2010
Stromal cell-derived factor-1/CXCL12 contributes to MMTV-Wnt1 tumor growth involving Gr1+CD11b+ cellsBob Y Liu, Irina Soloviev, Peter Chang, et al.
Nature Cell Biology|March 16, 2010
Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25AYaron Pereg, Bob Y Liu, Karen M O'Rourke, et al.
The AAPS Journal|October 1, 2025
A Fit-for-purpose Strategy for Clinical Immunogenicity Assessment of Multivalent Bispecific AntibodiesZhaojun Yin, Bob Y Liu, Ben Ordonia, et al.
Blood Advances|July 25, 2018
CLT030, a leukemic stem cell-targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemiaYing-Ping Jiang, Bob Y Liu, Quan Zheng, et al.
Plos One|September 22, 2010
Wnt isoform-specific interactions with coreceptor specify inhibition or potentiation of signaling by LRP6 antibodiesYan Gong, Eric Bourhis, Cecilia Chiu, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Biology : CB|April 13, 2010
Primary cilia regulate branching morphogenesis during mammary gland developmentKimberly M McDermott, Bob Y Liu, Thea D Tlsty, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2004
The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cellsBob Y Liu, Sean P McDermott, Shariq S Khwaja, et al.
Oncogene|December 19, 2003
Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulationBob Y Liu, Young Chul Kim, Vicki Leatherberry, et al.
BMC Developmental Biology|February 20, 2007
Wnt signaling induces differentiation of progenitor cells in organotypic keratinocyte culturesMarni A Slavik, B Lynn Allen-Hoffmann, Bob Y Liu, et al.
Cancer Research|February 7, 2012
Mammary tumor regression elicited by Wnt signaling inhibitor requires IGFBP5Bob Y Liu, Irina Soloviev, XiaoDong Huang, et al.
Plos One|January 21, 2010
Stromal cell-derived factor-1/CXCL12 contributes to MMTV-Wnt1 tumor growth involving Gr1+CD11b+ cellsBob Y Liu, Irina Soloviev, Peter Chang, et al.
Nature Cell Biology|March 16, 2010
Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25AYaron Pereg, Bob Y Liu, Karen M O'Rourke, et al.
The AAPS Journal|October 1, 2025
A Fit-for-purpose Strategy for Clinical Immunogenicity Assessment of Multivalent Bispecific AntibodiesZhaojun Yin, Bob Y Liu, Ben Ordonia, et al.
Blood Advances|July 25, 2018
CLT030, a leukemic stem cell-targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemiaYing-Ping Jiang, Bob Y Liu, Quan Zheng, et al.
Plos One|September 22, 2010
Wnt isoform-specific interactions with coreceptor specify inhibition or potentiation of signaling by LRP6 antibodiesYan Gong, Eric Bourhis, Cecilia Chiu, et al.
Pageof 2